Codes ATC:
J05AR03
Indication
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
Code ICD11:
1C62.Z
INN
Emtricitabine + tenofovir
Type de médicament
Chemical agent
Type de liste
Liste de base
Formulations
Oral > Solid:
200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)
Historique des statuts LME
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended lamivudine be specified a as therapeutic alternative for the emtricitabine component under the square box listing for emtricitabine + tenofovir on the EML.